BioLASCO Taiwan Co., Ltd. (TPEX:6662)
Taiwan · Delayed Price · Currency is TWD 29.35
-0.10 (-0.34%)
Aug 26, 2026, 9:09 AM CST
BioLASCO Taiwan Market Cap
BioLASCO Taiwan has a market cap or net worth of 754.27 million as of August 26, 2026. Its market cap has decreased by -8.26% in one year.
Market Cap
754.27M
Enterprise Value
700.02M
Revenue
258.04M
Ranking
n/a
PE Ratio
18.53
Stock Price
29.35
ChartMarket Cap Chart
Since January 4, 2018, BioLASCO Taiwan's market cap has decreased from 1.58B to 754.27M, a decrease of -52.29%. That is a compound annual growth rate of -8.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 754.27M | -5.00% |
| Dec 31, 2025 | 793.97M | -6.34% |
| Dec 31, 2024 | 847.76M | -0.30% |
| Dec 29, 2023 | 850.32M | 11.22% |
| Dec 30, 2022 | 764.52M | -1.97% |
| Dec 30, 2021 | 779.89M | -13.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneReach Biotechnology | 979.88M |
| TCI GENE | 940.60M |
| Lukas Biomedical | 933.80M |
| Meribank Biotech | 931.93M |
| Holy Stone Healthcare | 915.26M |
| NatureWise Biotech & Medicals | 798.52M |
| SynCore Biotechnology Co.,Ltd | 703.29M |
| Taiwan Advance Bio-Pharmaceutical | 676.80M |